Non-coding RNAs, epigenetics, and cancer: tying it all together

Humberto J. Ferreira,Manel Esteller

DOI: https://doi.org/10.1007/s10555-017-9715-8

2018-01-26

Cancer and Metastasis Reviews

Abstract:While only a small part of the human genome encodes for proteins, biological functions for the so-called junk genome are increasingly being recognized through high-throughput technologies and mechanistic experimental studies. Indeed, novel mechanisms of gene regulation are being discovered that require coordinated interaction between DNA, RNA, and proteins. Therefore, interdisciplinary efforts are still needed to decipher these complex transcriptional networks. In this review, we discuss how non-coding RNAs (ncRNAs) are epigenetically regulated in cancer and metastases and consequently how ncRNAs participate in the sculpting of the epigenetic profile of a cancer cell, thus modulating the expression of other RNA molecules. In the latter case, ncRNAs not only affect the DNA methylation status of certain genomic loci but also interact with histone-modifying complexes, changing the structure of the chromatin itself. We present several examples of epigenetic changes causing aberrant expression of ncRNAs in the context of tumor progression. Interestingly, there are also important epigenetic changes and transcriptional regulatory effects derived from their aberrant expression. As ncRNAs can also be used as biomarkers for diagnosis and prognosis or explored as potential targets, we present insights into the use of ncRNAs for targeted cancer therapy.

oncology

What problem does this paper attempt to address?

This paper aims to explore the epigenetic regulatory mechanisms of non - coding RNAs (ncRNAs) in cancer and the metastasis process, and analyze how ncRNAs participate in shaping the epigenetic profiles of cancer cells, thereby regulating the expression of other RNA molecules. Specifically, the paper discusses how ncRNAs change chromatin structure by interacting with histone - modifying complexes, and how they affect the DNA methylation status of certain loci. In addition, the paper also provides several examples of abnormal ncRNA expression in tumor progression caused by epigenetic changes, and explores the possibility of ncRNAs as cancer diagnosis, prognosis or potential treatment targets.

In short, the problem this paper attempts to solve is: how are non - coding RNAs epigenetically regulated during cancer development and metastasis, and how do these ncRNAs in turn affect the epigenetic state of cancer cells, thereby affecting gene expression and the cancer process.